uk

State of Medtech

State of Medtech

Health EN ↓ Епізодів: 433

State of Medtech is the #1 podcast in medtech and medical devices. Hosted by Omar M. Khateeb, we go inside the business and science of healthcare innovation—with unfiltered interviews from top investors, startup founders, and industry leaders. Each week, we feature candid interviews with:💼 Top medtech investors & VCs🧠 Founders of disruptive medical device startups🧬 Clinicians & industry leaders shaping the future of medicineFrom go-to-market to M&A, AI to surgical robotics, this is your edge for scaling, funding, and selling in medtech. New episodes weekly.

Обов'язково відвідайте сайт подкасту та підтримайте його автора: podcasters.spotify.com

Автор

State of Medtech

Категорія

Health

Сайт подкасту

podcasters.spotify.com

Останній епізод

18 лис 2026

Де слухати?

Подкасти в застосунку Replaio Radio Уже незабаром

Подкасти незабаром з'являться в застосунку. Встановіть уже зараз і першими побачте зовсім новий погляд на подкасти

Завантажити з Google Play Встановіть безкоштовно Android 10 млн+ завантажень · рейтинг 4,7+ iOS незабаром

Епізоди

408. Travis Kalanick’s Lessons on Fundraising, Scale and Resilience for MedTech Founders 19.08.2026

In this solo episode, Omar Khateeb translates some of Uber founder Travis Kalanick’s strongest lessons on fundraising, scale, leadership, and resilience into practical ideas for MedTech founders. The discussion begins with a powerful operating principle: companies can only scale as quickly as their organizations can solve the problems created by growth. FDA clearance, new indications, commercializ...

407. The Sleep Apnea Treatment Renaissance: Amir Reuveny, CEO of Wesper, on Reinventing Diagnosis 17.08.2026

In this episode, Dr. Amir Reuveny, Founder and CEO of Wesper , joins Omar Khateeb to unpack why sleep diagnostics are becoming increasingly important as the treatment landscape for sleep apnea expands. Amir shares how watching his father struggle with unrecognized sleep apnea eventually connected with his academic work in flexible electronics, leading him to build technology designed around comfor...

406.Why Most MedTech Investor Decks Fail and What Actually Persuades 12.08.2026

Watch Omar’s Market Engineering Training: https://youtu.be/KSy8tZGMfCo?si=WGedZ_VJ1oCkITNfJoin Omar at Medtech CEO Camp in Boston. Use code MC1000 for $1,000 off. https://www.campcuriae.com/ In this solo episode, Omar Khateeb explains why most MedTech investor decks fail to create conviction and how founders can build presentations that make the market opportunity, adoption path, and use of capita...

405. Venture: Neurotech’s Next Billion-Dollar Breakthrough with Amy Kruse of Satori Capital 10.08.2026

In this episode, Omar Khateeb speaks with Amy Kruse, General Partner and Chief Investment Officer at Satori Neuro, about the intersection of neuroscience, neurotechnology, AI, brain health innovation, and venture capital. A neuroscientist, DARPA leader, defense executive, entrepreneur and investor, Amy explains Satori Neuro's ecosystem approach. Interests include neuromodulation, precision psy...

404.Peter Thiel's Company Building Framework Every MedTech Founder Should Master 05.08.2026

In this solo episode, Omar Khateeb examines Peter Thiel’s most overlooked lesson for MedTech founders: breakthrough technology does not create its own path to customers, investors, clinicians, or commercial adoption. Drawing from the sales and distribution chapter of Zero to One , Omar explains why commercialization begins long before FDA clearance or product launch. A MedTech company is already s...

403.How Mike Minogue Built Abiomed Into a $17B MedTech Unicorn and Now Wants to be Massachusetts' Next Governor 03.08.2026

Michael Minogue, 2026 Republican Endorsed Candidate for Governor of Massachusetts , President and CEO of Minogue Consulting , and former CEO of Abiomed , joins Omar Khateeb to share the leadership principles behind one of MedTech's most remarkable growth stories. The conversation explores how Abiomed evolved from a struggling company into a $17 billion MedTech leader by creating an entirely ne...

402. Market Engineering and the Science Behind MedTech Category Leadership 29.07.2026

In this episode, Omar Khateeb explores why commercialization is not a launch event but a long-term process of engineering market belief. Strong technology, FDA clearance, clinical validation, and venture funding reduce technical risk, yet they do not guarantee that physicians, investors, or strategic acquirers will change their behavior. The discussion introduces the principles of Market Engineeri...

401. NeuroTech Investing Is Entering the Human 3.0 Era with Brom Rector and Samantha Rector of XEIA Venture Partners 27.07.2026

The future of healthcare may be shaped less by incremental innovation and more by technologies that fundamentally change how we understand the human brain. In this episode, Omar Khateeb is joined by Brom Rector, Founder of XEIA Venture Partners , and Samantha Rector, General Partner of XEIA Venture Partners , for an in-depth conversation about neurotechnology, AI, longevity, venture capital, and t...

400. Venture: Reacting to H1 2026 with Henry Peck of LSI and Jon Norris of HSBC Innovation Banking 23.07.2026

Click here to get the 2026 H1 HSBC Report https://www.marketcraft.ai/resources/hsbc-venture-healthcare-report-2026 In this episode, Omar Khateeb sits down with Henry Peck of LSI and Jon Norris, Managing Director of HSBC Innovation Banking , to analyze the H1 2026 Mid Year Healthcare Venture Trends Report and explain what today's healthcare investment landscape means for founders, investors, ex...

399. Why MedTech Needs a Bubble to Create the Next Trillion Dollar Industry 15.07.2026

Innovation rarely arrives through incremental improvements. It emerges when industries become willing to fund thousands of parallel experiments around a shared vision of the future. In this solo episode, Omar Khateeb explores why productive bubbles have repeatedly accelerated humanity's greatest technological breakthroughs and why MedTech may need its own period of ambitious experimentation to...

398. Physical AI: The AI Platform That Could Transform Open Surgery with Peter Verrillo, CEO of Redefine Surgery 13.07.2026

Building the Intelligence Platform for Modern Surgery. The next breakthrough in surgery may not come from another robot. It may come from intelligence. In this episode, Omar Khateeb speaks with Peter Verrillo, CEO of Redefine Surgery, about building the technology platform that brings computer vision, Physical AI, and world models into the operating room. Peter shares why Collaborative Surgical In...

397.Category Design 101: Why Category Strategy Beats Product Strategy 08.07.2026

Winning markets rarely begins with building a better product. It begins with changing how customers think. In this solo episode, Omar Khateeb explores why category design is the first discipline of Market Engineering and how market leaders consistently create new buying frameworks before competitors recognize the opportunity. Using examples from Tesla, Red Bull, Intuitive Surgical, and the Play Bi...

396. AI Strategy: The Invisible Shift Every CEO Must Understand with Harry Glorikian of Scientia Ventures 06.07.2026

Enterprise AI: Why the Interface Matters More Than the Mode! Most conversations about artificial intelligence focus on models. The real transformation is happening somewhere else. In this episode, Omar Khateeb welcomes Harry Glorikian, General Partner at Scientia Ventures, to discuss how invisible interfaces, AI agents, enterprise workflows, and organizational redesign are changing the future of b...

395.This Month in MedTech: Medtronic's Double Bet, a New Heart Valve Market & $92M for Male Birth Control 01.07.2026

This Month in MedTech What the Biggest MedTech Deals Reveal About the Future of Healthcare. June delivered one of the clearest signals yet about where MedTech strategy is heading. In this episode, Omar Khateeb speaks with Henry Peck, Chief Business Officer at LSI, about the deals, investment patterns, and strategic decisions defining the current MedTech market. The discussion covers Medtronic’s tw...

394.How AI Powered Implants Need a New Energy Platform with Omari Bouknight of Resonant Link Medical 29.06.2026

The Infrastructure Behind Intelligent Medical Devices. Medical innovation is becoming increasingly intelligent. The infrastructure supporting those devices must evolve just as quickly. In this episode, Omar Khateeb speaks with Omari Bouknight, CEO & Board Director of Resonant Link Medical, about the role wireless power will play in the future of implantable healthcare. The conversation covers...

393.Why Most MedTech Startups Lose After Finding Product Market Fit and Never Build Durable Market Power 24.06.2026

Why Product Market Fit Is Only the Beginning! Most startups spend years chasing traction. Very few spend enough time understanding what happens after they achieve it. In this solo episode, Omar Khateeb explains why product-market fit creates opportunity but does not create protection. Growth attracts customers, but it also attracts competitors, capital, strategic interest, and market attention. Th...

392. Improving Breast Surgery Outcomes Through a Prehabilitation Platform with Saahil Mehta of Plexāā 22.06.2026

Most surgical innovation focuses on what happens during or after a procedure. Saahil Mehta believes the bigger opportunity may exist before surgery ever starts. In this episode, Omar Khateeb speaks with the Founder of Plexāā about prehabilitation, tissue conditioning, breast reconstruction, patient education, and the role preparation plays in long-term recovery. The discussion examines how heat sh...

391. Why Early Adopters Are a Risk for Medtech Startups Scaling to Mainstream Market 17.06.2026

In this solo episode, Omar Khateeb explores why many startups struggle immediately after gaining traction. The challenge is rarely the technology. The challenge is the buyer. Early adopters and mainstream customers make decisions for completely different reasons. One group rewards innovation and vision. The other rewards certainty, references, evidence, and proven outcomes. The conversation examin...

390. Neuromod: How non-invasive ultrasound neuromodulation could change autoimmune disease treatment with Nishant Doctor of Surf Therapeutics 15.06.2026

Omar Khateeb speaks with Nishant Doctor, Founder, CEO, and CTO of Surf Therapeutics , about the next frontier of neurotechnology: using ultrasound neuromodulation to target inflammation. Nishant breaks down the science behind the cholinergic anti-inflammatory pathway, why the splenic nerve may offer a more direct target than the vagus nerve, and how non-invasive stimulation could create a differen...

389.Should You Quit Your Job for a Startup? The Psychology of Startups vs Corporations Through the Barbarians to Bureaucrats Framework 10.06.2026

The Psychology of Startups vs Corporations. In this solo episode, Omar Khateeb examines the hidden forces that shape career satisfaction, professional growth, and long term success. Using the Barbarians to Bureaucrats framework, the conversation explores how organizations evolve through different stages and why each stage attracts a different type of personality. Visionaries, builders, operators,...

388.Market Engineering with Bruce Cleveland of Traction Gap Partners 08.06.2026

Why Great Markets Create More Value Than Great Products! In this episode, Omar Khateeb speaks with Bruce Cleveland, Chief Executive Officer of Traction Gap Partners and author of Market Engineering , about one of the most overlooked drivers of company success: market creation. Drawing from his experience helping build Oracle, Siebel Systems, and C3 AI, Bruce explains why many companies focus heavi...

387. This Month in MedTech: Q1 Earnings, M&A Momentum, and the Rise of Focused Strategics 03.06.2026

In this episode of This Month in MedTech , Omar Khateeb speaks with Nicholas Talamantes, Sr. Director at Life Science Intelligence, about the market signals shaping MedTech right now. The discussion covers Q1 earnings from major strategics, the rise of focused growth platforms, Boston Scientific’s $1.5B bet on structural heart , and the latest M&A activity from J&J, Medtronic, ResMed, Roch...

386.Matt Curl of Apollo.io on Why Modern Go To Market Is Becoming the Biggest Competitive Advantage in Business 01.06.2026

In this episode, Omar Khateeb speaks with Matt Curl, Chief Executive Officer at Apollo.io , about AI native go to market systems, modern revenue growth, and why great products rarely win markets on their own. Matt shares how Apollo.io built one of the leading go to market platforms serving hundreds of thousands of businesses worldwide and explains why modern GTM now depends on real time data, auto...

385. How to manage your board using the Elephant Slide 27.05.2026

In this episode, Omar Khateeb explores the Elephant Slide framework and why it is becoming an essential leadership tool in MedTech boardrooms. The discussion breaks down why disconnected operational updates often create fragmented board conversations around clinical milestones, financing, regulatory progress, commercialization, and market confidence. Omar explains how strong CEOs use strategic nar...

384: Venture: Virginia Giddings of Edwards Lifesciences & Deborah Kilpatrick of Sonder Capital 25.05.2026

In this episode, Omar Khateeb speaks with Deborah K. and Virginia Giddings of Edwards Lifesciences about the future of MedTech innovation, venture capital, and strategic investment. The conversation explores why great technology and clinical superiority alone rarely create adoption in MedTech. Topics include startup failure rates, acquisition pathways, AI-enabled robotics, minimally invasive thera...

Слухайте подкаст State of Medtech у Replaio

Радіо та подкасти в одному застосунку - безкоштовно й без реєстрації. Встановіть уже сьогодні та не пропустіть запуск

Завантажити з Google Play

Replaio не є видавцем подкастів; назви шоу, обкладинки та аудіо належать їхнім авторам і поширюються через публічні RSS-канали